1. Epithelial–mesenchymal plasticity in kidney fibrosis
    Sudarat Hadpech et al, 2024, genesis CrossRef
  2. Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
    Xue Tong et al, 2022, Frontiers in Pharmacology CrossRef
  3. Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
    Peng Liu et al, 2023, Frontiers in Endocrinology CrossRef
  4. Research progress of endothelial‐mesenchymal transition in diabetic kidney disease
    Ying Chen et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
  5. The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications
    Kun Yang et al, 2023, Frontiers in Endocrinology CrossRef
  6. Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism
    Jing Zhang et al, 2022, Journal of Pharmaceutical and Biomedical Analysis CrossRef
  7. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
    Xiaoju Ma et al, 2023, Renal Failure CrossRef
  8. Potential therapeutic effects of natural compounds targeting autophagy to alleviate podocyte injury in glomerular diseases
    Tongtong Liu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  9. Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)
    Yujia Zheng et al, 2023, International Journal of Molecular Medicine CrossRef
  10. Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy
    Moein Ala et al, 2023, Journal of Diabetes Research CrossRef
  11. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis
    Xueru Hu et al, 2024, International Immunopharmacology CrossRef
  12. LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits autophagy of pancreatic cancer cells through the miR-532 /TWIST1 signaling pathway
    Hui Wu et al, 2023, Cancer Cell International CrossRef
  13. Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
    Tong Jiang et al, 2022, Integrative Medicine in Nephrology and Andrology CrossRef
  14. Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy
    Fengzhao Liu et al, 2024, Frontiers in Pharmacology CrossRef
  15. Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-β1 in Autophagy and Kidney Fibrosis
    Miss Ruby et al, 2023, Cells CrossRef
  16. Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease
    Xian Wang et al, 2022, Frontiers in Pharmacology CrossRef
  17. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
    Pengyu Tao et al, 2022, Frontiers in Immunology CrossRef
  18. Naringenin inhibits autophagy and epithelial‐mesenchymal transition of human lens epithelial cells by regulating the Smad2/3 pathway
    Qingnan Li et al, 2022, Drug Development Research CrossRef
  19. Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research
    Lirong Lin et al, 2022, Frontiers in Pharmacology CrossRef
  20. Impaired autophagic flux and dedifferentiation in podocytes lacking Asah1 gene: Role of lysosomal TRPML1 channel
    Guangbi Li et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef